The results demonstrated that the expression of glucose transporter 1 (GLUT1) and breast cancer-resistance protein (BCRP) were positively correlated to HER2-positive breast cancer but negatively correlated with triple negative breast cancer, indicating that HER2-positive breast cancer maintains BBB integrity [57]. The gene discussed is ERBB2; the disease is breast carcinoma.